Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer

Anticancer Research

Volumn 20, Issue 5 C, 2000, Pages 3727-3734

  Iwagaki, H ^a   Tanaka, N ^a   Esato, K ^a   Kaibara, N ^a   Sano, K ^a   Dohi, K ^a   Nakamura, T ^a   Nakasato, H ^a   Orita, K ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

5 Fluorouracil and 1 hexylcarbamoyl 5 fluorouracil; Adjuvant chemotherapy; Colorectal cancer

Indexed keywords

CARMOFUR; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; RECTAL NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 0034528702     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Pattern of recurrence following curative resection of adenocarcinoma of the colon and rectum
2. Patterns of recurrence of rectal cancer after potentially curative surgery
3. Prognostic factors for patients with colon or rectal carcinoma treated with resection only: Five-year follow-up report
4. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
5. Randomized controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma
6. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery
7. Antitumor activity of carbamoyl derivatives of 5-fluorouracil by oral administration
8. Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in a variety of experimental tumors
9. Antitumor activity of metabolites of 1-hexylcarbamoyl-5-fluorouracil and related compounds against L1210 leukemia in vivo and L5178Y lymphoma cells in vitro
10. Absorption and excretion of a new oral antitumor drug, 1-hexylcarbamoyl-5-fluorouracil (HCFU), in cancer patients
11. Metabolic fate of 1-hexylcarbamoyl-5-fluorouracil in rats
12. Antitumor activity of 1-alkylcarbamoyl derivatives of 5-fluorouracil in a variety of mouse tumors
13. Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in Lewis lung carcinoma and B16 melanoma
14. Enhancement of antitumor effects of 1-hexylcarbamoyl-5-fluorouracil combined with hyperthermia on Ehrlich ascites tumor in vivo and Nakahara-Fkuoka sarcoma cell in vivo
15. Sensitivity test for 5-fluorouracil and its analogues, 1-(2-tetrahydrofuryl)-5-fluorouracil, uracil/1-(2-tetrahydrofuryl)-5-fluorouracil(4: 1) and 1-hexylcarbamoyl-5-fluoprouracil, using the subrenal capsule assay
16. Modulation by 1-leucovorin of 1-hexylcarbamoyl-5-fluorouracil antitumor activity on human gastric and colon carcinoma serially transplanted into nude mice
17. Clinical trials of a new anticancer drug, 1-hexylcarbamoyl- 5-fluorouracil
18. 1-hexylcarbamoyl-5-fluorouracil (HCFU) - A masked 5-fluorinated pyrimidine
19. Am J Clin Oncol (CCT)
20. Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: Carboquone, adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil
21. Comparison of in vitro anticancer chemosensitivity between human squamous cell carcinoma and adenocarcinoma
22. Chemotherapy of large bowel cancer
23. An analysis of chemotherapy for colorectal carcinoma
24. Phase II evalation of ftorafur in previously untreated colorectal cancer
25. Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: Five-year follow-up. Tokai HCFU Study Group-Third Study on Colorectal Cancer
26. Mitomycin C plus carmofur (HCFU) adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma
27. Sequential treatment assignment with balancing prognostic factors in the controlled clinical trial
28. The randomization and stratification of patients to clinical trials
29. Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection
30. Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
31. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
32. Effects of cancers and their treatment on host immunity